Valuation : BioGaia AB

Market Cap 11.68B 1.23B 1.05B 987M 902M 1.7B 117B 1.71B 4.53B 58.97B 4.6B 4.5B 195B P/E 2026 *
30.2x
P/E 2027 * 24.6x
Enterprise Value 11.02B 1.16B 992M 931M 850M 1.6B 110B 1.61B 4.27B 55.6B 4.34B 4.24B 184B EV / Sales 2026 *
6.6x
EV / Sales 2027 * 5.88x
Free-Float
80.82%
Yield 2026 *
2.55%
Yield 2027 * 2.77%
1 day+0.09%
1 week+0.96%
Current month+0.43%
1 month-0.26%
3 months-9.08%
6 months+8.20%
Current year+9.32%
1 week 113.8
Extreme 113.8
117.8
1 month 110.3
Extreme 110.3
117.8
Current year 97.5
Extreme 97.5
136.3
1 year 96.2
Extreme 96.2
136.3
3 years 91.45
Extreme 91.45
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 48.6
Extreme 48.6
139.7
Manager TitleAgeSince
Chief Executive Officer 60 30/09/2023
Director of Finance/CFO 59 05/11/2019
Chief Operating Officer 49 01/01/2021
Director TitleAgeSince
Chairman 77 01/01/2003
Chairman 76 25/04/2018
Director/Board Member 46 01/01/2015
Date Insider Type Main position Quantity % Market Cap.
13/02/26 Buy

Director

582 0.0006%
30/12/25 Buy

General Counsel

390 0.0004%
05/12/25 Buy

Chief Financial Officer

2,000 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
+0.22%+0.96%+16.27%+14.50% 1.23B
-2.25%-3.10%+38.65%-1.87% 81.36B
-5.77%-14.18%+505.18%+33.71% 59.75B
+0.84%+4.44%-19.19%-35.11% 59.19B
+0.76%+3.53%+0.08%+36.18% 53.33B
+1.22%+2.62%+11.13%+172.09% 49.09B
+0.14%-0.22%+61.70%-16.40% 32.66B
-1.23%-0.27%+52.52%+100.63% 25.97B
-2.00%+6.32%+18.24%+209.64% 24.39B
+0.88%+0.60%+61.74%+123.69% 16.91B
Average -0.67%+0.18%+74.63%+63.70% 40.39B
Weighted average by Cap. -1.00%-1.00%+93.18%+48.18%

Financials

2026 *2027 *
Net sales 1.67B 175M 150M 141M 129M 243M 16.7B 244M 647M 8.43B 658M 643M 27.91B 1.88B 197M 169M 159M 145M 273M 18.77B 275M 727M 9.47B 739M 723M 31.37B
Net income 387M 40.59M 34.84M 32.7M 29.87M 56.37M 3.87B 56.64M 150M 1.95B 152M 149M 6.47B 474M 49.72M 42.67M 40.05M 36.58M 69.04M 4.74B 69.37M 184M 2.39B 187M 183M 7.92B
Net Debt -667M -69.96M -60.05M -56.36M -51.48M -97.15M -6.67B -97.62M -258M -3.37B -263M -257M -11.15B -646M -67.71M -58.11M -54.54M -49.82M -94.02M -6.46B -94.47M -250M -3.26B -254M -249M -10.79B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change
27/08/26 SEK 116.10 +0.52%
26/08/26 SEK 115.50 -1.37%
25/08/26 SEK 117.10 +0.69%
24/08/26 SEK 116.30 +0.35%
21/08/26 SEK 115.90 +1.05%
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
115.50SEK
Average target price
152.50SEK
Spread / Average Target
+32.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock